Chamber and committees

The Scottish Government’s role is to set the strategic policy for the NHS in Scotland and provide core funding to NHS boards. NHS boards have responsibility for deciding how to use this core funding to deliver services locally based on the needs of the people in their area.

The Joint Committee on Vaccination and Immunisation (JCVI) advise flu vaccination for those aged 65 years and over. During the COVID-19 pandemic, Scotland expanded the programme to protect individuals, public services and the NHS. During the COVID-19 pandemic, Scottish Government made a policy decision to expanded the programme to protect individuals, public services and the NHS.

Eligibility criteria for the last three years are set out below.

2024-25:

• Residents in long-stay care homes / facilities
• Those aged 65+
• Those aged 18 to 64 at risk including:
  • clinical at-risk groups as per Green Book Chapter 19 (GBC19)
  • the homeless
  • those experiencing substance misuse
  • asylum seekers in Home Office hotel accommodation
  • prisoners
  • pregnant women
• Frontline health and social care workers
• Non-frontline NHS workers
• Poultry workers & bird keepers
• Unpaid carers and young carers
• Household contacts of the immunosuppressed
• Those aged 6 months to 2 years at clinical risk
• Those aged 2-5 years not yet at school
• Primary & secondary school children

2023-24:

• Residents in long-stay care homes / facilities
• Those aged 50 +
• Those aged 18 to 49 at risk including:
  • clinical at-risk groups as per GBC19
  • the homeless
  • those experiencing substance misuse
  • prisoners
  • pregnant women
• Frontline health and social care workers
• Non-frontline NHS workers
• Poultry workers
• Teachers
• Prison staff
• Unpaid carers and young carers
• Household contacts of the immunosuppressed
• Those aged 6 months to 2 years at clinical risk
• Those aged 2-5 years not yet at school
• Primary & secondary school children

2022-23:

• Residents in long-stay care homes / facilities
• Those aged 50 +
• Those aged 18 to 49 at risk including:
  • clinical at-risk groups as per GBC19
  • the homeless
  • those experiencing substance misuse
  • prisoners
  • pregnant women
• Frontline health and social care workers
• Non-frontline NHS workers
• Teachers
• Prison staff
• Unpaid carers and young carers
• Household contacts of the immunosuppressed
• Those aged 6 months to 2 years at clinical risk
• Those aged 2-5 years not yet at school
• Primary & secondary school children

The Scottish Government recognises that funding will be required to support Boards to make the transition to a reformed maternity and neonatal service. We are continuing to provide transitional funding to Boards, as we have done for NHS GGC and NHS Lothian since 2019, with additional support for NHS Grampian now being included. This funding is focused on supporting Boards through the transition process.

We have been working with the regional implementation leads on development of plans for implementation to include a business case (or equivalent operational financial plan) with costs, with the expectation that a phased transition to the new model will begin in the new year.

To date, we have provided over £30 million of funding to NHS Boards to support implementation of the Best Start recommendations, and we are currently looking at future funding for maternity services in the next financial year.

The figures below relate to Endometriosis research funding directly awarded following a competitive independent review process either through Chief Scientist Office’s (CSO) project funding committees, or fellowship funding panels.

This includes the 2022 Scottish Government collaboration with Wellbeing of Women on a £250,000 research call. The research is primarily being run by researchers at The University of Edinburgh and will look at a non-hormonal drug in the management of endometriosis-associated pain.

Most awards are multi-year. The figures below relate to the year in which the funding was committed rather than a breakdown by year of the spend profile for individual projects or fellowships

2007 0

2008 0

2009 0

2010 0

2011 0

2012 £110,198

2013 0

2014 0

2015 £27,639

2016 0

2017 0

2018 £162,651

2019 £30,000

2020 0

2021 0

2022 £394,510

2023 £349,999

2024 £623,028

Full details of CSO’s direct research funding awards are available from the CSO website Funded Research – Chief Scientist Office

The Scottish Government collaborated with Wellbeing of Women on a £250,000 research call in April 2022. The research is primarily being run by researchers at The University of Edinburgh and will look at a non-hormonal drug in the management of endometriosis-associated pain.

The research will be funded over 3 years with the research findings expected to be disseminated in December 2025.

In January 2023 the Chief Scientist Office announced funding of £299,509 for the 30 month ENDOCAN project, led by researchers at The University of Edinburgh. Through a large scale UK-wide trial, the research will investigate whether a cannabinoid can reduce endometriosis-associated pain.

Recruitment for the study is due to start in August 2025 in NHS Lothian and NHS Grampian. More information can be found on the research being undertaken by The University of Edinburgh can be found on their website.

The Health and Social Care Alliance Scotland (the ALLIANCE) has continued to support the Women’s Health Plan through their dedicated lived experience programme, including a Women’s Health Lived Experience Stakeholder Group, to help us continue our conversation with women, and ensure women are meaningfully involved in decision making and priority setting going forward.

More information can be found in the ALLIANCE Final Report on Women’s Health Plan.

The Scottish Government provides baseline funding to NHS Boards, which Boards use to best meet the healthcare needs of their resident population. Funding is not ring-fenced for the treatment of endometriosis. It is not therefore possible to identify funding allocated specifically for endometriosis.

Through the Women’s Health Plan, a range of funding has been provided for resources and research related to improving endometriosis care.

The Scottish Government collaborated with Wellbeing of Women on a £250,000 research call in 2022. The research is primarily being run by researchers at The University of Edinburgh and will look at a non-hormonal drug in the management of endometriosis-associated pain.

The Chief Scientist Office announced funding of £299,509 for the 30 month ENDOCAN project in January 2023, led by researchers at The University of Edinburgh. Through a large scale UK-wide trial, the research will investigate whether a cannabinoid can reduce endometriosis-associated pain.

The Scottish Government also provided £24,000 of funding in August 2023 to Endometriosis UK to deliver a project creating new resources to support people with endometriosis.

The costs associated with establishing an identity for Qualifications Scotland were set out in the Financial Memorandum that accompanied the Education (Scotland) Bill and were the best estimate available at the time.

A cost relating to the creation of an identity of a new public body will always be incurred and Qualifications Scotland is no exception. I requested that my officials look at ways to bear down on costs where possible while still delivering an identity for Qualifications Scotland. I can confirm that officials have been working closely with the SQA on this, to ensure that value for money for taxpayers is achieved.

The priorities of the ILG will flex and take account of changing economic and policy circumstances, but will continue to develop actions in the Retail Strategy on:

(a) Fair Work -The Industry Leadership Group will take forward the action on Fair Work, working with members to produce a Fair Work document which will showcase good examples of Fair Work in the sector and contain useful resources for organisations, using the valuable insight gained from the Fair Work Working Group (FWWG).

(b) Just Transition - The ILG will work across industry to share expertise and promote best practice.

(c) Retail skills - An audit has been completed, and an action plan has been drafted, with priority areas identified. Discussions are currently taking place with Skills Development Scotland, Scottish Government Employability Division and other stakeholders, including Local Employability Partnerships, to implement and evaluate a pilot approach to developing a pipeline of trained, informed and motivated individuals to compete for available jobs in the retail sector.

Following the advice of the Joint Committee on Vaccination and Immunisation (JCVI), which provides advice on immunisation to all four UK nations, for winter 2024, COVID-19 vaccination is being offered to the following groups in Scotland:

Residents in care homes for older adults

All adults aged 65 years and over

Individuals aged 6 months and over who are in a clinical at risk group (as defined in tables 3 and 4 in the COVID-19 chapter of the Green Book), including pregnant women

Frontline Health & Social Care Workers

Staff in care homes for older adults

The key change in eligibility this winter, compared to winter 2023, is that unpaid carers and household contacts of the immunosuppressed are no longer eligible for COVID-19 vaccination this winter, as per the advice of the JCVI.

The JCVI noted that they no longer advise COVID-19 vaccination for frontline health and social care workers and staff in care homes for older adults, but advised that health and social care service providers may wish to consider vaccination as an occupational health programme.

The Scottish Government made the decision to continue the offer of COVID-19 vaccination to frontline health and social care workers, and staff in care homes for older adults for winter 2024. We will begin to assess the need for any future offer for these two groups in early 2025.